March 19, 2018 / 9:02 PM / a year ago

BRIEF-Novartis files patent infringement against Regeneron over latter's manufacture of Eylea, Zaltrap

March 19 (Reuters) - Novartis files patent infringement lawsuit against regeneron over latter's manufacturing of eylea, zaltrap -- court filing Novartis alleges that eylea, zaltrap incorporate technology covered by one or more claims of a patent it holds Novartis says the patent in question dates from 1997 and is called 'vector for expression of a polypeptide in a mammalian cell' Novartis seeks compensatory and triple damages for renegeron's alleged willful patent infringement, in a lawsuit filed with the u.s. District court in manhattan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below